---
title: "Opdivo (nivolumab), all indications: Storage and supply questions"
description: "Storage and supply questions on Opdivo (nivolumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: How supplied and Storage. Questions: What vial sizes do Opdivo and Opdivo Qvantig come in? What are the NDC codes for Opdivo and Opdivo Qvantig? How should Opdivo and Opdivo Qvantig vials be stored? 3 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/opdivo/storage-and-supply"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Opdivo (nivolumab), all indications: Storage and supply questions

Manufacturer: Bristol-Myers Squibb Company  
Prescribing information: [Opdivo](https://packageinserts.bms.com/pi/pi_opdivo.pdf)  
Indication pages: [Metastatic non-small cell lung cancer](https://www.evicenter.com/medical-information/opdivo--metastatic-non-small-cell-lung-cancer)

## How supplied

<a id="opdivo-strengths"></a>

### What vial sizes do Opdivo and Opdivo Qvantig come in?

> “Injection: 40 mg/4 mL (10 mg/mL), 100 mg/10 mL (10 mg/mL), 120 mg/12 mL (10 mg/mL), 
> and 240 mg/24 mL (10 mg/mL) clear to opalescent, colorless to pale-yellow solution in a 
> single-dose vial.”

Source: [OPDIVO: OPDIVO, page 7, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_opdivo.pdf#page=7)

> “Injection: 300 mg nivolumab and 5,000 units hyaluronidase per 2.5 mL (120 mg/2,000 units 
> per mL), as a clear to opalescent, colorless to yellow solution in a single-dose vial.”

Source: [OPDIVO: OPDIVO Qvantig, page 6, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_opdivo-qvantig.pdf#page=6)

> “Injection: 600 mg nivolumab and 10,000 units hyaluronidase per 5 mL (120 mg/2,000 units 
> per mL), as a clear to opalescent, colorless to yellow solution in a single-dose vial.”

Source: [OPDIVO: OPDIVO Qvantig, page 6, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_opdivo-qvantig.pdf#page=6)

<a id="opdivo-ndc"></a>

### What are the NDC codes for Opdivo and Opdivo Qvantig?

> “OPDIVO<sup>®</sup> (nivolumab) Injection is a clear to opalescent, colorless to pale-yellow solution in a 
> single-dose vial available as follows:
> Carton Contents
> NDC
> 40 mg/4 mL (10 mg/mL) single-dose vial
> 0003-3772-11
> 100 mg/10 mL (10 mg/mL) single-dose vial
> 0003-3774-12
> 120 mg/12 mL (10 mg/mL) single-dose vial
> 0003-3756-14
> 240 mg/24 mL (10 mg/mL) single-dose vial
> 0003-3734-13”

Source: [OPDIVO: OPDIVO, page 56, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_opdivo.pdf#page=56)

> “OPDIVO QVANTIG™ (nivolumab and hyaluronidase-nvhy) injection is a sterile, preservative-free, 
> clear to opalescent and colorless to yellow solution for subcutaneous use. It is supplied as an 
> individually packaged single-dose vial as follows:
> Carton Contents
> NDC
> 300 mg nivolumab and 5,000 units hyaluronidase per 2.5 mL
> (120 mg/2,000 units per mL) single-dose vial
> 0003-3120-01
> 600 mg nivolumab and 10,000 units hyaluronidase per 5 mL
> (120 mg/2,000 units per mL) single-dose vial
> 0003-6120-01”

Source: [OPDIVO: OPDIVO Qvantig, page 47, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_opdivo-qvantig.pdf#page=47)

## Storage

<a id="opdivo-storage"></a>

### How should Opdivo and Opdivo Qvantig vials be stored?

> “Store under refrigeration at 2°C to 8°C (36°F to 46°F). Protect from light by storing in the original 
> package until time of use. Do not freeze or shake.”

Source: [OPDIVO: OPDIVO, page 56, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_opdivo.pdf#page=56)

> “Store OPDIVO QVANTIG vials in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton 
> to protect from light.
> Do not freeze or shake.”

Source: [OPDIVO: OPDIVO Qvantig, page 47, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_opdivo-qvantig.pdf#page=47)

## Related pages
- [Medical information: Opdivo (nivolumab): All indications](https://www.evicenter.com/medical-information/opdivo)
- [Indication](https://www.evicenter.com/medical-information/opdivo/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/opdivo/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/opdivo/safety)
- [Specific populations](https://www.evicenter.com/medical-information/opdivo/specific-populations)
